Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice.
about
Tissue-type plasminogen activator is a neuroprotectant in the central nervous systemCell based therapies for ischemic stroke: from basic science to bedsideSubacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in ratsRecombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-AnalysisValproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activityExosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth.Exosomes/miRNAs as mediating cell-based therapy of strokePlasminogen deficiency causes reduced corticospinal axonal plasticity and functional recovery after stroke in mice.Multipotent mesenchymal stromal cells increase tPA expression and concomitantly decrease PAI-1 expression in astrocytes through the sonic hedgehog signaling pathway after stroke (in vitro study).Subacute intranasal administration of tissue plasminogen activator increases functional recovery and axonal remodeling after stroke in ratsMesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPAMultipotent mesenchymal stromal cells decrease transforming growth factor β1 expression in microglia/macrophages and down-regulate plasminogen activator inhibitor 1 expression in astrocytes after stroke.The sonic hedgehog pathway mediates brain plasticity and subsequent functional recovery after bone marrow stromal cell treatment of stroke in mice.The role of astrocytes in mediating exogenous cell-based restorative therapy for strokePromoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation.Neural stem cells: therapeutic potential for neurodegenerative diseases.Intravascular stem cell transplantation for stroke.Bone marrow stromal cell therapy for ischemic stroke: A meta-analysis of randomized control animal trials.Cell Therapy for Multiple Sclerosis.Stem cell-based therapies for ischemic stroke.tPA regulates neurite outgrowth by phosphorylation of LRP5/6 in neural progenitor cells.Cell-based therapeutic strategies for multiple sclerosis.Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB.Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis.Enhancing endogenous capacity to repair a stroke-damaged brain: An evolving field for stroke research.
P2860
Q26782904-6CCE2811-934B-47A3-BA96-BD745BD73BCDQ27025754-721E7C61-CC0F-48B7-A756-3661DE6DC3C6Q28542725-96620DDB-CBCF-45EE-9114-F2F208224C86Q28552445-A4CD8203-CACA-40A7-900D-83D6A20B062EQ28581097-33F0E539-08DE-4840-8CCA-6A624728529FQ34275817-64F6D512-9BCF-407F-9721-B022D7035645Q34481082-E17678B5-C9A8-4662-AEF9-48BCC99FBD41Q35147639-166C67D0-FCE8-4A4E-901D-2899831DF734Q35534160-C01D110C-5EE3-4C29-9129-A44B2831DA04Q35675445-2CF69C97-3E65-407C-BCD4-C5D867356EE8Q36222296-70FF4E62-CC37-4271-9EE6-667CB14AFA78Q36919070-69EFF530-672D-4A6E-9639-44BFC92E0614Q36994328-BF17BC3D-DE75-4B5C-BD46-8794A3729DE5Q37627332-57205BF5-B21F-4FA4-8C43-43FFA91779B8Q37660239-01B7A461-D60C-4966-9562-BC808AD894F9Q38044370-2EF464C0-B2A1-474A-8A26-8445F2F056A9Q38170033-ACE9784C-646D-4DAF-BAE3-774009AA4CE2Q38802867-1994D25E-5560-45EE-8BCE-1CBB92484B59Q39233323-F5F76F87-B746-44A4-A587-2597C7470508Q41928171-76582815-7026-4BBE-87D1-AEC289A84BA6Q45902163-F6F91991-F788-480A-9703-52A69F5CC876Q47885870-03219FA6-8635-44E1-B922-03252A98AD57Q48180924-8E5CD753-8308-48CE-92F0-39BEA98CF202Q49961729-0E761116-E7D8-4555-AF26-C128F35CFC5BQ51767535-0DBE6989-E285-4B4B-B164-E82852FAD626
P2860
Endogenous tissue plasminogen activator mediates bone marrow stromal cell-induced neurite remodeling after stroke in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@ast
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@en
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@nl
type
label
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@ast
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@en
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@nl
prefLabel
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@ast
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@en
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@nl
P2093
P2860
P1433
P1476
Endogenous tissue plasminogen ...... modeling after stroke in mice.
@en
P2093
Hongqi Xin
Li Hong Shen
Rui Lan Zhang
Yisheng Cui
Zheng Gang Zhang
P2860
P304
P356
10.1161/STROKEAHA.110.593863
P407
P577
2011-01-06T00:00:00Z